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Received 22 August 2006; received in revised form 13 November 2006; accepted 22 November 2006AbstractIn five multicentre field trials, the efficacy and safety of a combination of oxantel/pyrantel/praziquantel (Dolpac1, Vetoquinol
SA) in the treatment of naturally acquired gastrointestinal nematode and/or cestode infestation in dogs was evaluated in northern
and southern Europe.
Forty-eight investigators from France, Belgium, Germany, Italy and Spain enrolled 329 dogs to be treated with the tested
combination; 235 of these dogs complied with the inclusion criteria of the protocol and had a tested helminth identified on Day 0. A
pooled analysis was performed on each of the following helminth species: Toxocara canis, Ancylostoma caninum, Toxascaris
leonina, Trichuris vulpis, Uncinaria stenocephala, Taenia spp. and Dipylidium caninum, which were isolated on Day 0.
The main efficacy criterion was the egg per gram (epg) percent reduction of the nematodes and the absence of proglottids and or
eggs for the cestodes. After treatment, dogs were examined on Day 7, Day 14 and Day 21. The efficacy of the combination against
Toxocara canis was 99.1%, 98.8% and 98.9% on Day 7, Day 14 and Day 21, respectively. At the same occasions the efficacy was,
respectively, 99.2%, 99.2% and 99.3% against Ancylostoma caninum, 97.3%, 97.2% and 98.4% against Trichuris vulpis, 98.4%,
98.8% and 98.8% against Uncinaria stenocephala, 98.9%, 99.5% and 99.9% against Toxascaris leonina, 97.1%, 100% and 100%
against Dipylidium caninum and 100% against Taenia spp.
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Infections with intestinal helminths are common in
dogs in Europe. Toxocara canis is the most frequently
encountered, mainly in puppies, with prevalences
ranging 3–30%. Toxascaris leonina is found less
frequently, with 0.5–10% positive dogs. The prevalence
of the whipworm, Trichuris vulpis, is highly variable
E. Grandemange et al. / Veterinary Parasitology 145 (2007) 94–99 95(0–47.6%), with higher values in kennel dogs and adult
dogs compared to household dogs and young dogs. The
hookworm Uncinaria stenocephala is more commonly
found in stray dogs and shelter dogs (2.2–34.7%) than in
household dogs (0–13.1%). Ancylostoma caninum is
only present in southern Europe. Only low prevalences
are found for the tapeworms Dipylidium caninum and
Taenia spp. (0–8%) (Vanparijs and Thienpont, 1973;
Haralabidis et al., 1988; Vanparijs et al., 1991; Deplazes
et al., 1995; Causape´ et al., 1996; Franc et al., 1997;
Overgaauw, 1997; Beugnet et al., 2000; Fok et al., 2001;
Barutzki and Schaper, 2003; Habluetzel et al., 2003; Le
Nobel et al., 2004; Epe et al., 2004).
Anthelmintics or combinations of anthelmintics with
a broad spectrum of activity are relevant to treat the
polyparasitism currently encountered in dogs in the
field. The anthelmintic product (Dolpac1) tested in this
study is a combination of pyrantel pamoate, oxantel
pamoate, and praziquantel. It is a broad spectrum
anthelmintic for oral use in dogs. Pyrantel is an L-type
cholinergic agonist with good anthelmintic activity
against ascarids and hookworms (Cadiergues and Franc,
1994), but no activity against whipworms. Oxantel is a
meta-oxphenyl derivative of pyrantel (N-type choliner-
gic agonist, Martin et al., 2004) that was first introduced
for the treatment of whipworms in children. It is also
highly potent for the treatment of Trichuris muris in
mice (Rajasekariah et al., 1991). Praziquantel is a
pyrazinoisoquinoline that is currently the drug of choice
for the treatment of a wide range of cestode infections
(Day et al., 1992). Anthelmintic products combining
pyrantel, oxantel and praziquantel are available in
several countries for use in dogs (e.g. New-Zealand,
Australia, Chile), but are not commonly used in Europe
(except for Italy). Thus, in order to assess the efficacy of
the combination in field conditions in Europe, a study
with the same experimental design was carried out in
five European countries. The primary objective was to
evaluate in the field the efficacy and safety of such a
combination in the treatment of nematode (A. caninum,
Toxocara canis, Toxascaris leonina, Trichuris vulpis, U.
stenocephala) and/or cestode (D. caninum, Taenia sp.,)
infections in dogs.
2. Materials and methods
2.1. Experimental design
Theexperimental designwas amulticentre field study.
Overall five studies, one for each country, were carried
out in Belgium, France, Germany, Italy and Spain. In
each country, one reference laboratory was elected tocarry out the faecal examinations for the inclusion of
dogs into the study and for its follow up after treatment.
All studies were conducted in compliance with the
Committee for Veterinary Medical Products European
Union Note for Guidance ‘‘Good Clinical Practice for
Conduct of Clinical Trials For Veterinary Medical
Products’’ (July 2001). Informed consent was obtained
from the animals’ owners before enrolment.
2.2. Selection of animals
Owned dogs of any breed and sex, aged more than 2
months and suspected to have an intestinal helmintic
infection were selected for the trials. Pregnant bitches
(in the first 4 weeks of pregnancy), dogs weighing less
than 1 kg, dogs with a concurrent disease or pre-existing
surgical conditions, dogs treated with anthelmintic
compounds within the 60 previous days (except
preventive products effective against heartworm larval
stages only) and dogs with a history of idiosyncrasy to
one or more of the compounds used in the study were
not included. The presence of intestinal parasites was
first confirmed by macroscopic/microscopic faecal
examinations carried out by the veterinarians partici-
pating in the study or throughout a pre-inclusion
analysis carried out by the reference laboratory. Dogs
were included into the studies only after a definitive
diagnosis of intestinal helminth infection throughout
quali-quantitative faecal examinations carried out by
the reference laboratory in charge for the faecal
analyses in each country.
2.3. Treatment
Three formulations of the test drug were available
(divisible in half tablets corresponding to 2 kg b.w.,
10 kg b.w., or 25 kg b.w.) to treat the dogs according to
their body weight allowing a mean dosage of 20 mg/kg
of oxantel, 5 mg/kg of pyrantel and 5 mg/kg of
praziquantel). The same formulations (Dolpac1,
Vetoquinol SA, batch numbers: 010604A, 01064B,
010604C) were used for all the studies. The tested
products were under evaluation and were not launched
at the time of the study.
2.4. Efficacy and safety assessment and faecal
analyses
Themain efficacy criterion was the percent reduction
of the faecal egg counts per gram (epg) for the
nematodes and the presence/absence of proglottids/eggs
for the cestodes after treatment. When the efficacy was
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tids/eggs were present in a given dog at a given time, it
was considered as a treatment failure.
Dogs were clinically evaluated and their faeces
sampled on Day 0 (inclusion visit), Day 7 (first follow-
up visit), Day 14 (second follow-up visit) and Day 21
(final visit).
The epg counts were carried out by the reference
laboratories using the sameMacMaster method. Briefly,
4 g of faeces were suspended in 60 ml of saturated NaCl
water solution (density: 1.2). The suspension was used
to fill the MacMaster cells (sensitivity = 25 epg for four
counted compartments and 50 for two counted
compartments). When no eggs were found using the
MacMaster slide, a direct faecal flotation using the
prepared suspension was carried out to confirm the
negative results. A test-tube of 10 ml was filled with the
faecal suspension and centrifuged at low speed
(1500  g). The surface of the suspension was gently
collected and dropped on a glass slide and covered with
a 20 mm  20 mm cover glass. When parasite eggs
were found as a consequence of the higher sensitivity of
the direct flotation, the eggs under the cover glass were
counted and these counts were used for the statistical
analysis. Differentiation of hookworm eggs was done
by morphological features (Thienpont et al., 1979).Table 1
Number and percentage of dogs infected with intestinal helminths at inclu
Parasite species
Ancylostoma caninum
Toxocara canis
Trichuris vulpis
Uncinaria stenocephala
Dipylidium caninum
Taenia spp.
Ancylostoma caninum, Trichuris vulpis
Ancylostoma caninum, Uncinaria stenocephala
Ancylostoma caninum, Dipylidium caninum
Toxocara canis, Ancylostoma caninum
Toxocara canis, Toxascaris leonina
Toxocara canis, Trichuris vulpis
Toxocara canis, Uncinaria stenocephala
Toxocara canis, Dipylidium caninum
Trichuris vulpis, Taenia spp.
Trichuris vulpis, Uncinaria stenocephala
Dipylidium caninum, Taenia spp.
Ancylostoma caninum, Trichuris vulpis, Dipylidium caninum
Toxocara canis, Trichuris vulpis, Ancylostoma caninum
Toxocara canis, Trichuris vulpis, Toxascaris leonina
Toxocara canis, Toxascaris leonina, Uncinaria stenocephala
Toxocara canis, Trichuris vulpis, Uncinaria stenocephala
Trichuris vulpis, Uncinaria stenocephala, Taenia spp.The adverse events observed throughout the study
were reported and analyzed.
2.5. Statistical analysis
The egg counts from all the studies were pooled and
analyzed together. The percentage of epg reduction at
each study time with respect to the counts on Day 0 was
calculated after a natural log transformation of epg
[ln(x + 1)]. Geometric mean (GM) egg counts for each
species and for each study time were estimated from
least squares means of the ln(epg count + 1). GM were
used to estimate percent reduction in epg counts after
treatment: % reduction = [epg GM on Day 0  epg GM
on day n (where n is the different times of the study)/epg
GM on Day 0]  100. The results were analyzed by a
non-parametric paired test (Wilcoxon-signed rank test)
to evaluate the statistical value of the epg count
reduction after treatment (the significance level was set
at 5%). When for a given dog a faecal sample was
missed on a given day after treatment, the egg reduction
was estimated on this day using the GM of Day 0
calculated without the egg count of this given dog in
order to have the same sample size.
As the efficacy against the cestodes was assessed as
presence/absence, no statistical analysis was performed.sion in the trial (Day 0)
Number of dogs Percentage of positive dogs
14 6
61 26
56 24
17 7
27 11.5
7 3
4 1.7
1 0.4
3 1.3
3 1.3
2 0.9
14 6
1 0.4
2 0.9
1 0.4
13 5.5
1 0.4
1 0.4
2 0.9
1 0.4
1 0.4
1 0.4
2 0.9
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Table 2
Geometric mean (GM), range and percentage reduction of faecal egg counts (epg) of nematode parasites in 235 dogs treated with a combination of
pyrantel pamoate, oxantel pamoate and praziquantel
Parasite (infected dogs) Day 0 Day 7 Day 14 Day 21
Ancylostoma caninum (28) epg GM 173.1 1.4 1.3 1.2
Range 1–25,000 0–50 0–50 0–150
% reduction 99.2 99.2 99.3
Toxocara canis (88) epg GM 422.9 4 5.3 4.65
Range 1–85,150 0–7,150 0–5,100 0–4,400
% reduction 99.1 98.8 98.9
Toxascaris leonina (4) epg GM 882.2 10.1 4.1 0
Range 175–3,350 0–200 0–275 0–0
% reduction 98.9 99.5 99.9
Trichuris vulpis (95) epg GM 207.9 5.6 6 3.3
Range 1–105,000 0–700 0–2,500 0–600
% reduction 97.3 97.2 98.4
Uncinaria stenocephala (36) epg GM 151.1 2.5 1.8 1.8
Range 1–3,600 0–250 0–300 0–350
% reduction 98.4 98.8 98.8
Table 3
Number of dogs positive at faecal examinations for proglottids of
cestodes before (day 0) and after (days 7, 14 and 21) treatment with a
combination of pyrantel pamoate, oxantel pamoate and praziquantel
and percentage reduction of infected dogs after treatment
Parasite Day 0 Day 7 Day 14 Day 21
Dipylidium caninum
Infected dogs 34 1 0 0
% reduction 97.1 100 100
Taenia spp.
Infected dogs 11 0 0 0
% reduction 100 100 1003. Results
Overall, 20 veterinary investigators in France, 4 in
Belgium, 8 in Germany, 11 in Italy and 5 in Spain
enrolled 329 dogs. Two hundred and thirty-five dogs
complied with the inclusion criteria and intestinal
helminth infections were identified on D0.
Animals of different sexes (male, neutered male,
female, spayed female) and breeds with a large range
of weight (1.4–68.7 kg b.w., arithmetic mean of
20 kg, median 18 kg) and age (aged 2 months to 15
years, arithmetic mean of 3.5 years, median 2 years)
were included in the studies. Four dogs had clinical
signs of infection at inclusion (diarrhoea) and 22 were
sharing kennels with untreated dogs throughout the
study.
Out of the 235 positive dogs, 182 dogs (77%) had a
single species infection, 45 were infected (19%) by 2
worm species and 8 by 3 worm species (4%) (Table 1).
Thus, on Day 0, of 235 dogs 95 were positive to
Trichuris vulpis (40.4%) and 88 to Toxocara canis
(37.4%) as a single infection or in association with other
parasites. Toxocara canis was found as a single
infection in 61 dogs (26%) and Trichuris vulpis in 56
dogs (24%), respectively. U. stenocephala and A.
caninum were found in 36 (15%) and 28 (12%) dogs,
respectively. The prevalence of hookworm single
infections accounted 7% for U. stenocephala and 6%
for A. caninum (Table 1). Toxascaris leonina was found
only in four dogs (2%) and always associated with other
parasites. Proglottids of D. caninum were found in 34
dogs (15%); in 27 dogs the parasite was found as asingle infection (11.5%). Proglottids of Taenia spp.
were found in 11 dogs (5%); in 7 dogs the parasite was
found as a single infection (3%).
Overall, the epg counts decreased >97% compared
with Day 0 on each post-treatment sampling for the
nematodes Toxocara canis, A. caninum, Toxascaris
leonina, Trichuris vulpis, and U. stenocephala
( p < 0.0001, Table 2). Similarly, the number of dogs
positive for proglottids/eggs of D. caninum and/or
Taenia spp. was reduced more than 97% on each faecal
examination after treatment (Table 3).
Individual treatment failures (i.e. egg count reduc-
tion <90%) are summarized in Table 4. Most treatment
failures were found for Toxocara canis and Trichuris
vulpis. Twelve failures were observed for Toxocara
canis on D7 and occurred in very young dogs or dogs
presenting diarrhoea at inclusion. Four and five of these
dogs, showed an efficacy >90% on day 14 and 21,
respectively, while six and seven new failure cases were
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Table 4
Number of individual failures (epg counts reduction<90%) including
number of new failures at the different times of the study in bold
Parasite Day 7 Day 14 Day 21
Ancylostoma caninum 1 2 (1) 1 (1)
Toxocara canis 12 14 (6) 14 (7)
Toxascaris leonina 1 0 0
Trichuris vulpis 22 25 (13) 18 (7)
Uncinaria stenocephala 5 4 (1) 2 (1)found at the same times. Twenty-two failures were
observed on Day 7 for Trichuris vulpis. Twelve and 11
of these dogs showed an efficacy >90% on Day 14 and
21, respectively, while 13 and 7 new failure cases were
found at the same times. Only a few cases were found
for A. caninum and U. stenocephala.
Throughout the studies, veterinarians notified eight
adverse reactions. Overall, the frequency of suspected
adverse reaction was 2.4%. The reactions were
diarrhoea, vomiting and one case of transient anorexia
and reduced general health condition. All the observed
reactions were transient and mild and dogs recovered
spontaneously.
4. Discussion and conclusion
The results clearly show that the parasitism found in
dogs included in the different trials was representative
of worm infection in dogs in Europe. All the most
frequent helminth species were found with prevalences
and epg counts consistent with previous findings
including frequent isolation of potential zoonotic
worms, especially, Toxocara canis. Trichuris vulpis
and Toxocara canis alone or in association with other
helminth species were the most frequent parasites found
at inclusion into the studies. Furthermore, in some case
the number of eggs shed with faeces was very high (see
Toxocara canis and Trichuris vulpis epg ranges on Day
0, Table 2), confirming the high risk of environmental
contamination by faeces of infected dogs, untreated
against intestinal parasites. It is also interesting to note
that about 23% of dogs were infected by two or three
worm species, showing that polyparasitism is quite
common in field conditions. The anthelmintic efficacy
of the combination of pyrantel pamoate, oxantel
pamoate and praziquantel was close to 99% against
all the tested parasites at each study day, except for
Trichuris vulpis, where the efficacy was 97–98%.
Although faecal egg counts from different methods
were pooled to calculate the anthelmintic efficacy,
differences in sensitivity mainly affect low egg counts
and probably had a minor influence on the results.Although the overall epg reduction was very high,
some treatment failures were observed throughout the
study. Most Toxocara canis failures on Day 7 were
found in very young dogs (2-month-old) and in dogs
with diarrhoea. In these dogs, migrating larvae can be
present, which are not affected by the pyrantel pamoate.
Furthermore, diarrhoea can shorten the intestinal transit
time, affecting the efficacy of the anthelmintic
compounds. Most Trichuris failures were observed in
dogs recovered in kennels together with untreated dogs.
In some dogs, the failures were observed on days 14 and
21 and not on day 7 post-treatment. Pyrantel and oxantel
have rather a limited efficacy against immature stages,
therefore, after treatment some larvae may develop to
adult female worms and excrete eggs. Recently, Sager
et al. (2006) have shown that coprophagia should be an
important factor interpreting parasitological analyses.
In our studies, it is possible that immature, ingested eggs
may have contributed to the egg counts. Moreover,
residual eggs may have induced a bias. For both A.
caninum and U. stenocephala, the treatment failures
could be a consequence of the short prepatent period (2–
3 weeks) and the faecal eggs present on Day 21might be
due to re-infections after treatment. No obvious
association was observed between multiple infections
or infection level and treatment failure. Furthermore,
regurgitation of tablets by the dog could occur without
owners and investigators’ knowledge.
The pyrantel pamoate, oxantel pamoate and prazi-
quantel combination tablets were always well accepted
by dogs. The frequency of side effects was low and they
were already described in the literature for pyrantel and
praziquantel (Shmidl et al., 1981; Plumb, 1995).
Based on these results, it may be concluded that the
tested anthelmintic combination for dogs had shown a
satisfactory safety and efficacy, and is convenient for
the treatment and prevention of helminth infestation in
dogs.
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